Wallace Marshall has been intrigued by the question of what regulated cell size since his childhood, when a book showing electron microscope images of cells showed their remarkably regular shape and structure, and led him to wonder how this could be. He returns to the question in his introduction to BMC Biology‘s Forum article on the topic, which forms part of BMC Biology’s series on Cell geometry – and now in an audio interview.
Will there be a universal mechanism across organisms that determines how the size of a cell is regulated? Whilst Wallace thinks that the authors of our Forum article start to answer this important question in several different organisms, there is still …
At the 6th MiM – Pan African Malaria Conference in October, Malaria Journal sponsored the prize for the Best Emergent Scientist, which is awarded to the scientist who gave the best oral presentation.
Malaria Journal is pleased to announce the winner of the award is Dr Irene Masanja, a Senior Research Scientist from the Ifakara Health Institute, Tanzania. Irene received her PhD in Epidemiology from Basel University before returning to the Ifakara Health Institute to work on health policy analysis and improve health systems in Tanzania. She is currently working on assessing the quality of malaria case management in Tanzania by evaluating the effectiveness and safety of antimalarials in rural areas of the country.
Irene is a …
The theory of evolution by natural selection is unarguably the most influential in the history of biology, but it has been dogged with controversy since its inception, and not just because of ideological resistance to its implications for our ancestry. One of the more compelling obstacles to its acceptance has been the existence of extremely complex adaptive structures such as (famously) the eye, which seem to defy explanation by the gradual accrual of random changes. Darwin worried about it, and accepted the contribution of inheritance of acquired characters in part to explain the otherwise apparently inexplicable. This Lamarckist position became untenable however when Weismann established the separation of germline and soma in the late 19th century; and …
Elizabeth Moylan, Biology Editor at BioMed Central, joined the panel of a lively session on peer review at SpotOn London last Friday (#solo13peer). The debate was coordinated by Duncan Fraser, our Head of Platform Management & User Experience, and you can find his Storify round-up of the discussion below.
View the story “Open, Portable, Decoupled?” on Storify
And you can read more about some recent research into peer review conducted by our Biology and Medical Editors in this post from last week.
The UK’s National Health Service (NHS)—the fifth biggest organization in the world after the US Army, Chinese Army, Wal-Mart, and McDonalds—has more than 1.5 million patient interactions per day. It’s ripe for taking advantage of new big data technologies. Yesterday at the London O’Reilly Strata Conference: Making Data Work, I listened to two inspiring talks about what is being done with big NHS data and what we’ll soon be able to do—and by soon I mean next year.
One talk worth listening to was Francine Bennette’s “Data Nerding in Public Health” in which she describes some of the work the big data specialist Mastodon C as well as Ben Goldacre (@bengoldacre) are doing with publicly available data …
Born Too Soon is a global action report published in 2012 which involved collaboration from more than 50 organizations. The report provided the first-ever national, regional and global estimates of preterm birth and the major findings of the report are expanded upon in six new review papers. The articles are jointly funded by the charities Save the Children and March of Dimes and published in collaboration with the Partnership for Maternal, Newborn and Child Health and World Health Organization (WHO). The series is due to be published as a supplement in the journal Reproductive Health on Friday 15th November, and a detailed infographic providing key facts and figures from the series. You …
At BioMed Central, we’re passionate about neuroscience, with a strong portfolio of open access journals, ranging from those dedicated to the field, such as BMC Neuroscience, Molecular Brain and Journal of Neuroinflammation, to broader scope journals with a strong emphasis on advances in neuroscience.
We are committed to serving the community’s needs and continue to remain at the forefront of initiatives such as that of the Neuroscience Peer Review Consortium, co-chaired by Neural Development’s co-Editor-in-Chief, Josh Sanes.
This week, we are delighted to be attending SfN 2013 in San Diego, California, and to have the opportunity to meet with our editors, authors and reviewers, and engage with the research community.
If you are attending SfN and …
Peer review is a key process in the publication of scientific research, and often finds itself under scrutiny and the topic of debate. Discussions around the future of peer review and problems with current models have led to experiments with open peer review, post publication peer review and double-blind peer review. At BioMed Central we offer a range of peer review models across our journals, including (to name just a few) open peer review on GigaScience and the medical titles in the BMC series, BMC Biology’s re-review opt out policy, and Biology Direct’s now well established model of author-driven open peer review.
We’ve also recently been conducting some research of our Read more
Molecular and Cellular Therapies is a new BioMed Central journal, which publishes its first articles today. The journal is led by Editors-in-Chief Xiangdong Wang and Bryon Peterson, and the four Section Editors, Ulf Andersson Ørom, Andrew Badley, Marek Malecki and Dan Peer.
Molecular and Cellular Therapies aims to publish both basic and clinical research that helps to establish new therapies, exploring for example, pharmacokinetics, biomarkers and novel treatment applications. In recent years, cellular therapies have received greater consideration for their use in disease treatments across many clinical disciplines, and the journal therefore welcomes research from a range of fields, from genetics and biotechnology to drug development and delivery.
Submissions relating to all aspects of molecular and …